DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Quick Stats
Jan 30, 202665.3
AI Score
BUY0.76
Volume Ratio
Feb 12, 2026
Next Earnings
17
+ve Days (30d)
13
-ve Days (30d)
DXCM Stock Summary
Last updated Jan 30, 2026
DXCM is currently trading at $73.04, positioned below its 200-day moving average of $74.16, suggesting bearish momentum. The stock has a 52-week range of $54.11 to $93.25.
Technical Analysis: The 50-day moving average stands at $67.27, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 63.784, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.229, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates DXCM at 65.3/100 with a BUY recommendation.
DXCM (DexCom, Inc.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 63.784 |
| CMF (20) | 0.229 |
| ROC (10) | 6.319 |
| ADX (14) | 29.905 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 1.896 |
| AROONOSC (14) | 57.143 |
| WILLAMS %R (14) | -23.471 |
| MFI (14) | 81.706 |
DXCM Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
DXCM Price vs Max Options Open Interest
DXCM Max Change In Options Open Interest
DXCM Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DXCM Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DXCM Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DXCM Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DexCom, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
DXCM Moving Averages Analysis
DexCom, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
DXCM (DexCom, Inc.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 72.68 |
| 20 | 70.85 |
| 30 | 69.5 |
| 50 | 67.27 |
| 100 | 67.06 |
| 200 | 74.16 |
DXCM Fundamental Analysis
| P/E (Forward) | 29.6736 |
| P/E (Trailing) | 40.7556 |
| Market Cap ($) | 28.8 billion |
| Earnings/Share ($) | 1.8 |
| Net Proft Margin (%) | 0.1596 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 2.0671 |
| EPS Estimate Next Year ($) | 2.4795 |
| WallStreet Target Price ($) | 85.1923 |
| Most Recent Quarter |